For more than a century, everyday painkillers have been handed over pharmacy counters to ease headaches, joint aches and ...

Colton Jones, M.D., of The University of Texas San Antonio, discusses aspirin for colorectal cancer prevention after presenting research comparing GLP-1s with aspirin at the 2026 ASCO Gastrointestinal ...

A daily aspirin cuts cancer, but doctors say don't reach for the bottle yet. March 20, 2012— -- A daily aspirin may cut your risk of cancer, new research suggests. But doctors advise that there's ...

Scientists have described the “Eureka moment” when they discovered how aspirin may prevent some cancers from spreading. Their new research builds on existing evidence and suggests aspirin supports a ...

Your family’s history of cancer suggests a genetic component. Among genetically vulnerable individuals, low-dose aspirin appears to be useful in reducing the chance of certain malignancies (JAMA ...

One of aspirin’s most intriguing properties is its anti-cancer activity. A Swedish research study published in the New England Journal of Medicine (Sept. 18, 2025) concludes that aspirin can ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Your everyday pain reliever might be doing more than just easing headaches. A major new study published in JAMA Oncology reveals that regular aspirin use could significantly lower the risk of ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been observed with aspirin.

Aspirin is widely known for its heart attack prevention benefits, but a new study has also linked the common drug to a reduced risk of colorectal cancer. The study analyzed data from 107,655 men and ...

Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less ...